Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
11.51
-0.07 (-0.60%)
Jul 21, 2026, 9:53 AM EDT - Market open
Bioventus Market Cap
Bioventus has a market cap or net worth of $961.49 million as of July 21, 2026. Its market cap has increased by 131.46% in one year.
Market Cap
961.49M
Enterprise Value
1.22B
1-Year Change
131.46%
Ranking
Category
Stock Price
$11.51
ChartMarket Cap Chart
Since the IPO on February 11, 2021, Bioventus's market cap has increased from $713.47M to $961.49M, an increase of 34.76%. That is a compound annual growth rate of 5.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 784.52M | 57.44% |
| Dec 31, 2025 | 498.30M | -27.40% |
| Dec 31, 2024 | 686.36M | 106.84% |
| Dec 29, 2023 | 331.83M | 105.22% |
| Dec 30, 2022 | 161.69M | -81.23% |
| Dec 31, 2021 | 861.26M | 20.71% |
| Feb 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alphatec Holdings | 1.31B |
| CONMED | 1.30B |
| IRADIMED CORPORATION | 1.24B |
| Artivion | 1.22B |
| QuidelOrtho | 1.19B |
| Tandem Diabetes Care | 1.17B |
| Avanos Medical | 1.17B |
| PROCEPT BioRobotics | 1.09B |